Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Streptokinase antibody

Known as: Streptokinase Ab, anti streptokinase, ANTI-STREPTOKINASE 
Streptococcus spp. exoenzyme reagents are devices used to identify antibodies to Streptococcus spp. exoenzyme in serum. The identification aids in… Expand
National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

Antibodies, Bacterial
Streptokinase Ab:ACnc:Pt:Ser:QnStreptokinase Ab:Titr:Pt:Ser:Qn

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2009
Highly Cited
2009
Effect of intracoronary streptokinase administered immediately after primary percutaneous coronary intervention on long-term left ventricular infarct size, volumes, and function.
OBJECTIVES The purpose of this study was to investigate the reflections of the improvement in microvascular perfusion provided by… Expand
  • figure 1
  • figure 2
Is this relevant?
Highly Cited
2007
Highly Cited
2007
Intracoronary streptokinase after primary percutaneous coronary intervention.
BACKGROUND Microvascular perfusion is often impaired after primary percutaneous coronary intervention (PCI). We proposed that in… Expand
  • figure 1
  • table 1
Is this relevant?
Review
2005
Review
2005
Evaluation of poststreptococcal illness.
Group A beta-hemolytic streptococcal pharyngitis, scarlet fever, and rarely asymptomatic carrier states are associated with a… Expand
  • table 1
  • figure 1
Is this relevant?
Highly Cited
1987
Highly Cited
1987
A multicenter, randomized, placebo-controlled trial of a new form of intravenous recombinant tissue-type plasminogen activator (activase) in acute myocardial infarction.
A new, predominantly single chain preparation of recombinant tissue-type plasminogen activator was evaluated to determine… Expand
  • figure I
  • figure 2
  • table 2
  • table 3
  • table 5
Is this relevant?
Highly Cited
1986
Highly Cited
1986
Which patients benefit most from early thrombolytic therapy with intracoronary streptokinase?
The effect of thrombolysis in acute myocardial infarction on enzymatic infarct size, left ventricular function, and early… Expand
  • figure 1
  • table 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
Highly Cited
1985
Highly Cited
1985
The western Washington randomized trial of intracoronary streptokinase in acute myocardial infarction. A 12-month follow-up report.
After cardiac catheterization and coronary arteriography, 134 patients who had had an acute myocardial infarction were randomly… Expand
Is this relevant?
1984
1984
A randomized, angiographically controlled trial of intracoronary streptokinase in acute myocardial infarction.
Fifty-five patients with acute myocardial infarction evaluated within 4 hours of the onset of symptoms were entered into an… Expand
Is this relevant?
1984
1984
A randomized trial of intravenous and intracoronary streptokinase in patients with acute myocardial infarction.
The clinical effects of intravenous streptokinase in patients with acute myocardial infarction were compared with those of… Expand
  • table 1
  • figure 1
  • table 2
  • table 3
  • figure 2
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Prospective randomized trial of intravenous and intracoronary streptokinase in acute myocardial infarction.
To evaluate the relative thrombolytic efficacy and complications of intracoronary vs high-dose, short-term intravenous… Expand
  • table 1
  • figure 2
  • figure 4
  • figure 3
  • figure 5
Is this relevant?
Highly Cited
1983
Highly Cited
1983
Effect of interventions in salvaging left ventricular function in acute myocardial infarction: a study of intracoronary streptokinase.
The ability of intracoronary streptokinase (STK) infused early in acute myocardial infarction (MI) to salvage left ventricular… Expand
Is this relevant?
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE